Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Liabilities and Shareholders Equity: 2009-2025

Historic Liabilities and Shareholders Equity for Prestige Consumer Healthcare (PBH) over the last 17 years, with Mar 2025 value amounting to $3.4 billion.

  • Prestige Consumer Healthcare's Liabilities and Shareholders Equity rose 3.78% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 billion, marking a year-over-year increase of 2.43%. This contributed to the annual value of $3.4 billion for FY2025, which is 2.53% up from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Liabilities and Shareholders Equity stood at $3.4 billion for FY2025, which was up 2.53% from $3.3 billion recorded in FY2024.
  • Prestige Consumer Healthcare's Liabilities and Shareholders Equity's 5-year high stood at $3.7 billion during FY2022, with a 5-year trough of $3.3 billion in FY2024.
  • For the 3-year period, Prestige Consumer Healthcare's Liabilities and Shareholders Equity averaged around $3.4 billion, with its median value being $3.4 billion (2023).
  • Per our database at Business Quant, Prestige Consumer Healthcare's Liabilities and Shareholders Equity rose by 7.04% in 2022 and then decreased by 8.63% in 2023.
  • Yearly analysis of 5 years shows Prestige Consumer Healthcare's Liabilities and Shareholders Equity stood at $3.4 billion in 2021, then climbed by 7.04% to $3.7 billion in 2022, then decreased by 8.63% to $3.4 billion in 2023, then decreased by 1.05% to $3.3 billion in 2024, then climbed by 2.53% to $3.4 billion in 2025.